(PharmaNewsWire.Com, February 27, 2019 ) The In Vitro Diagnostics Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.
In this Study Includes the Analytical Depiction of the Global In-Vitro Diagnostics Along With the Current Trends and Future Estimations to Determine the Imminent Investment Pockets. Some Factors Are Anticipated To Either Drive Or Hamper The Market Growth.
The global in-vitro diagnostics market is segmented on the basis of product & services, technology, application, and end user. The product & services segment includes, reagents & kits, instruments, data management software, and services. The technology segment includes, immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, microbiology, hematology, urinalysis, and others. By application, the in-vitro diagnostics market is segmented into diabetes, infectious diseases, oncology, cardiology, autoimmune diseases, nephrology, and others. By end user, the in-vitro diagnostics market is segmented into hospitals, laboratories, academic institutes, point-of-care testing, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global in-vitro diagnostics market based on product & services, technology, application, and end user. It also provides market size and forecast till 2027 for overall in-vitro diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
The List of Companies
1. F. Hoffmann-La Roche Ltd 2. Danaher 3. BD 4. Abbott 5. Siemens AG 6. bioMérieux SA 7. Thermo Fisher Scientific Inc. 8. Bio-Rad Laboratories, Inc. 9. Agilent Technologies, Inc. 10. Johnson & Johnson Services, Inc.
The in-vitro diagnostics market is expected to witness growth at a rapid pace due to increasing geriatric population and related growth in the prevalence of chronic & infectious diseases, rising adoption of fully automated instruments & automation in laboratories, and growing awareness on personalized medicine. Also, development of condition-specific markers & tests, rising significance of companion diagnostics, growth opportunities in emerging countries are offering opportunities in the in-vitro diagnostics market growth.
Key questions answered in the report include • What will the market size and the growth rate be in 2027? • What are the key factors driving the global In-Vitro Diagnostics market? • What are the key market trends impacting the growth of the In-Vitro Diagnostics market? • What are the challenges to market growth? • Who are the key vendors in this market space?
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
